Mr William Jones

Characterization of the mechanism of IKK-epsilon oncogenic potential as a target to for the development of novel therapeutics for the treatment of breast cancer.

This site uses cookies in order to function properly. By continuing to browse, you agree that we can save them on your device. Privacy Policy.